Back to Rankings

ABBV

AbbVieB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ABBV vs peer average
63/100
ABBV vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 6 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

BMY is the first available peer comparator.

High oncology exposure and recent M&A-driven portfolio; peer on execution and patent/competition risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBMYBristol-Myers Squibb
ABBV
AbbVie
BMY
Bristol-Myers Squibb
Grade
B
C
Momentum
51
43
Value
62
70
Sentiment
54
51
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs BMY

ABBV / BMY
Grade Position
In line
ABBV vs. peer average (B vs. C)
63/100
Momentum
51
ABBV
Value
62
BMY
Sentiment
54
ABBV

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ABBV
1
BMY
BMY
C
60/100
+1
2
JNJ
JNJ
C
60/100
+1
3
MRK
MRK
B
80/100
Even
4
PFE
PFE
C
60/100
+1
5
AZN
AstraZeneca PLC Common
F
20/100
+3
BMY is the first peer returned for this comparison set.